# Venetoclax in Combination with Obinutuzumab in Previously Untreated Fit Patients with Chronic Lymphocytic Leukemia: A Canadian Cost-Utility Analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/venetoclax-in-combination-with-obinutuzumab-in-previously-untreated-fit-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Gijs van de Wetering,Carolyn Owen,Versha Banerji,Ariane Gosselin,Shivani Kamdar,Nancy Paul Roc,Lytske Bakker,Gargi Ratnaparkhi,Stéphane Barakat,Colin Vicente,Beenish S. Manzoor |
| Citations | 0 |
| DOI | 10.1007/s41669-025-00610-1 |
| Fields | Medicine,Social Sciences |
| Open Access | true |
| OA Status | gold |
| OA URL | https://link.springer.com/content/pdf/10.1007/s41669-025-00610-1.pdf |
| OpenAlex ID | https://openalex.org/W4416015139 |
| PMID | 41203994 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Nancy Paul Roc](https://scholariq.org/researchers/nancy-paul-roc/)

## Paper journal

- [PharmacoEconomics - Open](https://scholariq.org/journals/pharmacoeconomics-open/)

## Paper primary topic

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Paper topics

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.